Congressman Invests in Lesser-Known Small Cap Lift Truck Firm
Congressman's Stock Transactions: Rep. Tim Moore (R-N.C.) disclosed multiple stock purchases, including significant investments in Hyster-Yale Inc., totaling between $145,000 and $350,000, which has attracted social media attention.
Recent Trading Activity: Moore's recent trades included buying shares of Hyster-Yale on several occasions in November, following previous transactions in October and September, with no sales reported this time.
Market Impact: Following the news of Moore's purchases, Hyster-Yale's stock price surged from $28.12 to $35.03, raising questions about the implications of his trades, especially given the company's history with government contracts.
Additional Investments: Alongside Hyster-Yale, Moore also purchased shares in Genprex, a small clinical stage gene therapy company, marking one of the smallest stocks ever bought by a member of Congress, which is expected to draw further scrutiny.
Trade with 70% Backtested Accuracy
Analyst Views on HY
About HY
About the author

- Significant Order Growth: Hyster-Yale reported a 42% sequential and 35% year-over-year increase in bookings for Q4 2025, indicating early signs of demand recovery after a period of customer caution, particularly strong in the North American market.
- Cost Savings Initiatives: The strategic restructuring implemented in 2025 is expected to yield annual savings of $40 million to $45 million, alongside $15 million in savings already realized from Nuvera's strategic realignment, with total recurring savings projected to reach $85 million to $100 million by 2028.
- Financial Performance Review: Q4 revenues declined to $923 million due to delayed customer purchases, although operating cash flow improved to $57 million, reflecting significant inventory efficiency gains.
- Optimistic Future Outlook: Management anticipates Q1 2026 will mark the trough of the current cycle, followed by improvements in bookings and shipment volumes, with capital expenditures expected between $55 million and $75 million, indicating reliance on production enhancements.
- Significant Order Growth: Q4 2025 bookings surged 42% sequentially and 35% year-over-year, indicating early signs of demand recovery in the Americas, potentially laying the groundwork for future performance rebounds.
- Cash Flow Improvement: Operating cash flow increased to $57 million in Q4, primarily driven by enhanced inventory management efficiency, demonstrating the company's ability to maintain financial flexibility amid economic uncertainty.
- Revenue and Profit Decline: Q4 revenues fell to $923 million, a 14% year-over-year decrease, with an operating loss of $37 million, reflecting the adverse impact of reduced shipment volumes and approximately $40 million in tariff costs on financial performance.
- Cautious 2026 Outlook: Shipment volumes are expected to increase in the second half of 2026, although a small loss may occur in the first half; however, overall operating profit is anticipated to improve, showcasing the company's strategic adjustments in navigating market challenges.
- Disappointing Earnings: Hyster-Yale reported a Q4 non-GAAP EPS of -$2.06, missing expectations by $0.83, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Decline: The company’s Q4 revenue of $923.2 million represents a 13.7% year-over-year decline, although it exceeded market expectations by $6.77 million, the ongoing revenue drop may affect future liquidity and investment decisions.
- Uncertain Outlook: The implementation of a 10% Chinese tariff in the U.S. by November 2025, along with the expiration of the current Section 301 tariff exemption for lift truck parts in November 2026, will pressure the company’s cost structure and impact its market competitiveness.
- Demand Forecast Dependency: The company’s demand forecasts are based on booking trends, backlog levels, and market data, indicating sensitivity to market dynamics, with successful implementation of proactive initiatives being crucial for future growth recovery.
- Quarterly Financial Performance: Hyster-Yale reported a loss of $52.5 million in Q4, translating to a loss of $2.96 per share, with an adjusted loss of $2.06 per share, indicating significant pressure on the company's market competitiveness and profitability challenges.
- Annual Performance Overview: The company faced an annual loss of $60.1 million, or $3.40 per share, despite generating $3.77 billion in revenue, highlighting ongoing difficulties in cost management and market demand.
- Revenue Analysis: With Q4 revenue at $923.2 million, the relatively high income failed to convert into profit, reflecting an urgent need for the company to enhance operational efficiency and reduce costs.
- Market Outlook: Hyster-Yale's financial results may impact its future investment and expansion plans, prompting investors to closely monitor how the company addresses its current financial challenges to restore profitability.
- Significant Revenue Decline: Hyster-Yale reported total revenues of $3.769 billion for 2025, a 13% decrease year-over-year, primarily due to economic uncertainty dampening customer demand across all product lines.
- Increased Net Loss: The company experienced a net loss of $60.1 million in 2025, a stark contrast to a net income of $142.3 million in 2024, reflecting severe challenges amid high tariffs and weak market demand.
- Operating Profit Plummets: In Q4 2025, operating losses reached $37.2 million, a 215% decline from a profit of $32.3 million in the same quarter of 2024, indicating significant shortcomings in cost management and market adaptability.
- Uncertain Future Outlook: While the company anticipates gradual improvement in bookings for 2026, ongoing tariff policies and market uncertainties are expected to continue exerting pressure on overall financial performance, leading to greater profitability challenges.








